July 23, 2013
Ruling in favor of Finnegan client DuPont, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s judgment as a matter of law, finding that a patent application claim by Novozymes A/S lacks adequate written description. Finnegan represented DuPont in this matter.
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
Uncrustables Fame Ruling Sets Up Functionality Fight Over Crimped Edge
September 11, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.